Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques

Kuniaki Saito, Andrew Lackner, Sanford P. Markey, Melvyn P. Heyes

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Increased concentrations of the neuroactive kynurenine pathway metabolites, quinolinic acid (QUIN) and kynurenic acid (KYNA), occur in the CSF of humans infected with the human immunodeficiency virus and macaques infected with retroviruses, including the D/1/California serotype. In the present study, increased activity of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, occurred in cerebral cortex and lung of macaques with clinical SAIDS. Such increases provide a mechanism to accelerate the formation of kynurenine pathway metabolites in both systemic tissues and the central nervous system.

Original languageEnglish
Pages (from-to)353-356
Number of pages4
JournalBrain Research
Volume540
Issue number1-2
DOIs
Publication statusPublished - 01-02-1991

Fingerprint

Betaretrovirus
Indoleamine-Pyrrole 2,3,-Dioxygenase
Kynurenine
Macaca
Cerebral Cortex
Lung
Simian Acquired Immunodeficiency Syndrome
Kynurenic Acid
Quinolinic Acid
Retroviridae
Central Nervous System
HIV
Enzymes

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Saito, Kuniaki ; Lackner, Andrew ; Markey, Sanford P. ; Heyes, Melvyn P. / Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques. In: Brain Research. 1991 ; Vol. 540, No. 1-2. pp. 353-356.
@article{e06b10ff14cb453abbf7ffdc04c61823,
title = "Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques",
abstract = "Increased concentrations of the neuroactive kynurenine pathway metabolites, quinolinic acid (QUIN) and kynurenic acid (KYNA), occur in the CSF of humans infected with the human immunodeficiency virus and macaques infected with retroviruses, including the D/1/California serotype. In the present study, increased activity of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, occurred in cerebral cortex and lung of macaques with clinical SAIDS. Such increases provide a mechanism to accelerate the formation of kynurenine pathway metabolites in both systemic tissues and the central nervous system.",
author = "Kuniaki Saito and Andrew Lackner and Markey, {Sanford P.} and Heyes, {Melvyn P.}",
year = "1991",
month = "2",
day = "1",
doi = "10.1016/0006-8993(91)90536-5",
language = "English",
volume = "540",
pages = "353--356",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques. / Saito, Kuniaki; Lackner, Andrew; Markey, Sanford P.; Heyes, Melvyn P.

In: Brain Research, Vol. 540, No. 1-2, 01.02.1991, p. 353-356.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques

AU - Saito, Kuniaki

AU - Lackner, Andrew

AU - Markey, Sanford P.

AU - Heyes, Melvyn P.

PY - 1991/2/1

Y1 - 1991/2/1

N2 - Increased concentrations of the neuroactive kynurenine pathway metabolites, quinolinic acid (QUIN) and kynurenic acid (KYNA), occur in the CSF of humans infected with the human immunodeficiency virus and macaques infected with retroviruses, including the D/1/California serotype. In the present study, increased activity of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, occurred in cerebral cortex and lung of macaques with clinical SAIDS. Such increases provide a mechanism to accelerate the formation of kynurenine pathway metabolites in both systemic tissues and the central nervous system.

AB - Increased concentrations of the neuroactive kynurenine pathway metabolites, quinolinic acid (QUIN) and kynurenic acid (KYNA), occur in the CSF of humans infected with the human immunodeficiency virus and macaques infected with retroviruses, including the D/1/California serotype. In the present study, increased activity of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, occurred in cerebral cortex and lung of macaques with clinical SAIDS. Such increases provide a mechanism to accelerate the formation of kynurenine pathway metabolites in both systemic tissues and the central nervous system.

UR - http://www.scopus.com/inward/record.url?scp=0026035960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026035960&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(91)90536-5

DO - 10.1016/0006-8993(91)90536-5

M3 - Article

C2 - 1647247

AN - SCOPUS:0026035960

VL - 540

SP - 353

EP - 356

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -